Found 0 matching trials
A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients
PHASE3A Multi-center, Randomized, Double-blind, Controlled, and Parallel Phase II...
Location
Cancer Hospital Chinese Academy of Medical Sciences
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
PHASE2Background:
Diffuse large B-cell lymphoma is the most common type of non-H...
Location
National Institutes of Health Clinical Center
Selinexor in Combination With R-CHOP Followed by Selinexor Maintenance for Untreated EBV-positive DLBCL Patients
PHASE1This is a prospective, single-arm, multi-center, phase Ib/II clinical trial...
Location
Sun Yat-sen Universitiy Cancer Center
A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
PHASE2The goal of this research study is to evaluate the combination of study dru...
Location
University of Miami Sylvester Cancer Center
A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R or R-CHOP for Patients With Richter's Syndrome
PHASE2This research study is evaluating the combination of a study drug, venetocl...
Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCL
PHASE2Zanubrutinib, as a new generation of BTK inhibitors, has shown more potent ...
Location
Sun Yat-sen University Cancer Center
Lisatoclax Plus R-CHOP or Pola-R-CHP in Untreated DLBCL: A Phase Ib/II Study
PHASE1This is a prospective, multicenter, open-label Phase Ib/II clinical study d...
Location
Sun Yat-sen University Cancer Center
Orelabrutinib in Combination with R-CHOP for CD5-positive DLBCL Patients(Rocket Trial)
PHASE2This is a prospective, single-arm, multicenter, phase II clinical trial to ...
Location
Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University,
A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma
PHASE3This trial will compare tisagenlecleucel to standard of care in adult parti...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)
PHASE1The purpose of this trial is to measure the safety and effectiveness of epc...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Treatments Being Tested
rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisonerituximab and lenalidomiderituximab and bendamustinerituximab, cytarabine, dexamethasone, and oxaliplatin/carboplatingemcitabine and oxaliplatinEpcoritamabrituximab, cyclophosphamide, reduced dose of doxorubicin, vincristine, and prednisoneLenalidomiderituximab, ifosfamide, carboplatin, and etoposide phosphateEpcoritamabEpcoritamabEpcoritamabEpcoritamabEpcoritamabEpcoritamabEpcoritamabRituximab and LenalidomideEpcoritamab